비교리스트

 카트 문의
시장보고서
상품코드
1543978

세계의 이식 진단학 시장

Transplant Diagnostics
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 158 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 이식 진단학 시장은 2030년까지 63억 달러에 도달

2023년에 45억 달러로 추정되는 세계의 이식 진단학 시장은 2023-2030년 CAGR 5.0%로 성장하며, 2030년에는 63억 달러에 달할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 분자 어세이 기술은 CAGR 5.7%를 기록하며, 분석 기간 종료시에는 40억 달러에 달할 것으로 예측됩니다. 비분자 어세이 기술 분야의 성장률은 분석 기간 중 CAGR 4.0%로 추정됩니다.

미국 시장은 12억 달러로 추정, 중국은 CAGR 8.8%로 성장 예측

미국의 이식 진단학 시장은 2023년에 12억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 15억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 8.8%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.8%와 5.2%로 예측됩니다. 유럽에서는 독일이 CAGR 2.2%로 성장할 것으로 예측됩니다.

세계의 이식 진단학 시장 - 주요 동향과 촉진요인 정리

이식 진단학이란 무엇이며, 왜 중요한가?

이식 진단학이란 장기 이식의 적합성과 건강 상태를 평가하고 모니터링하는 데 사용되는 의료 검사 및 시술을 말합니다. 이러한 진단에는 조직 유형화, 교차 매칭, 거부반응 및 감염을 감지하기 위한 이식 후 모니터링 등이 포함됩니다. 이식 진단학은 적절한 기증자를 찾고, 거부반응을 예방하고, 이식받은 환자의 건강을 관리함으로써 장기 이식의 성공을 보장하는 데 중요한 역할을 합니다. 이러한 진단의 정확성과 신뢰성은 이식 결과를 개선하고 환자의 생존율을 높이는 데 필수적입니다.

기술 혁신은 시장에 어떤 영향을 미쳤을까?

기술 혁신은 이식 진단학 분야를 크게 발전시켰습니다. 중합효소연쇄반응(PCR) 및 차세대 염기서열분석(NGS)과 같은 분자진단 기술의 개발로 조직 유형화 및 교차 매칭의 정확도와 속도가 향상되었습니다. 이러한 기술들은 적합한 기증자를 보다 정확하게 식별하고 거부반응의 가능성을 조기에 발견할 수 있게 해줍니다. 바이오마커 탐색의 발전은 이식편의 건강 상태를 모니터링하고 감염을 감지할 수 있는 비침습적 검사의 개발로 이어졌습니다. 또한 인공지능(AI)과 머신러닝 알고리즘의 통합은 데이터 분석 및 예측 능력을 향상시켜 이식 환자 관리를 개선했습니다. 이러한 기술 발전은 이식 진단학의 범위와 효과를 확장하고 임상 현장에서의 채택을 촉진하고 있습니다.

주요 사용자와 그들의 니즈는?

이식 진단학의 주요 사용자는 이식 센터, 병원, 진단 실험실 및 연구 기관을 포함합니다. 이식 센터와 병원은 장기 이식의 적합성과 성공을 보장하기 위해 이러한 진단에 의존하고 있으며, 임상적 판단을 위해 정확하고 시기적절한 결과를 필요로 합니다. 진단 실험실에서는 이식 관련 다양한 검사를 수행하므로 처리량이 많고 신뢰할 수 있는 진단 툴이 요구됩니다. 연구개발 기관에서는 이식 면역학 연구와 새로운 진단 및 치료법 개발에 이식 진단학을 활용하기 위해 첨단 혁신적인 기술을 요구하고 있습니다. 각 사용자 그룹은 장기 이식과 관련된 복잡하고 중요한 프로세스를 지원하기 위해 높은 정확도, 신뢰성 및 사용 편의성을 제공하는 이식 진단학을 요구하고 있습니다.

이식 진단학 시장의 성장 동력은?

이식 진단학 시장의 성장은 장기 이식 증가, 진단 기술의 발전, 만성질환의 유병률 증가 등 여러 가지 요인에 의해 이루어지고 있습니다. 장기 부전 발생률 증가와 이식 기술의 발전으로 장기 이식에 대한 수요가 증가함에 따라 정확하고 신뢰할 수 있는 이식 진단학에 대한 필요성이 증가하고 있습니다. 분자진단, 바이오마커 탐색 등 진단 기술의 발전으로 이식 진단학의 정확도와 속도가 향상되어 임상 현장의 채택이 촉진되고 있습니다. 당뇨병, 고혈압 등 만성질환의 확산으로 장기부전이 증가하면서 이식 진단학에 대한 수요를 더욱 촉진하고 있습니다. 또한 이식 연구 및 진단 툴 개발에 대한 정부의 구상과 자금 지원은 시장 성장을 지원하고 있습니다.

조사 대상 기업의 예(주목 11사)

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장의 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 24.09.03

Global Transplant Diagnostics Market to Reach US$6.3 Billion by 2030

The global market for Transplant Diagnostics estimated at US$4.5 Billion in the year 2023, is expected to reach US$6.3 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Molecular Assays Technology, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.0 Billion by the end of the analysis period. Growth in the Non-Molecular Assays Technology segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.8% CAGR

The Transplant Diagnostics market in the U.S. is estimated at US$1.2 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Transplant Diagnostics Market - Key Trends & Drivers Summarized

What Are Transplant Diagnostics and Why Are They Critical?

Transplant diagnostics are medical tests and procedures used to evaluate and monitor the compatibility and health of organ transplants. These diagnostics include tissue typing, cross-matching, and post-transplant monitoring to detect rejection and infections. Transplant diagnostics play a crucial role in ensuring the success of organ transplants by identifying suitable donors, preventing rejection, and managing the health of transplant recipients. The accuracy and reliability of these diagnostics are essential for improving transplant outcomes and enhancing patient survival rates.

How Have Technological Innovations Impacted the Market?

Technological innovations have significantly advanced the field of transplant diagnostics. The development of molecular diagnostic techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), has improved the accuracy and speed of tissue typing and cross-matching. These technologies enable more precise identification of compatible donors and early detection of potential rejection. Advances in biomarker discovery have led to the development of non-invasive tests for monitoring graft health and detecting infections. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced data analysis and predictive capabilities, improving the management of transplant patients. These technological advancements have expanded the scope and effectiveness of transplant diagnostics, driving their adoption in clinical practice.

Who Are the Key Users and What Are Their Needs?

The key users of transplant diagnostics include transplant centers, hospitals, diagnostic laboratories, and research institutions. Transplant centers and hospitals rely on these diagnostics to ensure the compatibility and success of organ transplants, requiring accurate and timely results to guide clinical decisions. Diagnostic laboratories perform various transplant-related tests, demanding high-throughput and reliable diagnostic tools. Research institutions utilize transplant diagnostics to study transplant immunology and develop new diagnostic and therapeutic approaches, seeking advanced and innovative technologies. Each user group requires transplant diagnostics that offer high precision, reliability, and ease of use to support the complex and critical processes involved in organ transplantation.

What Is Driving Growth in the Transplant Diagnostics Market?

The growth in the transplant diagnostics market is driven by several factors, including the increasing number of organ transplants, advancements in diagnostic technologies, and the rising prevalence of chronic diseases. The growing demand for organ transplants, driven by the rising incidence of organ failure and improved transplant techniques, has increased the need for accurate and reliable transplant diagnostics. Advancements in diagnostic technologies, such as molecular diagnostics and biomarker discovery, have enhanced the precision and speed of transplant diagnostics, driving their adoption in clinical practice. The rising prevalence of chronic diseases, such as diabetes and hypertension, has led to an increase in organ failures, further fueling the demand for transplant diagnostics. Additionally, government initiatives and funding for transplant research and the development of diagnostic tools have supported market growth.

Select Competitors (Total 11 Featured) -

  • Becton, Dickinson and Company
  • Biofortuna Ltd.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CareDx, Inc.
  • F. Hoffmann-La Roche AG
  • GenDx
  • Hologic, Inc.
  • Illumina, Inc.
  • Immucor, Inc.
  • Luminex Corporation
  • Merck KgaA
  • Omixon
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Organ Failures
    • Advancements in Molecular Diagnostics
    • Growth in Personalized Medicine
    • Development of Non-Invasive Diagnostic Tools
    • Rising Adoption of Genetic Testing
    • Expansion of Organ Transplant Programs
    • Innovations in Biomarker Discovery
    • Increasing Funding for Transplant Research
    • Growth in Point-of-Care Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Non-Molecular Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Non-Molecular Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Reagent & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Reagent & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Transplant Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • INDIA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030
  • AFRICA
    • Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transplant Diagnostics by Technology - Molecular Assays and Non-Molecular Assays Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Transplant Diagnostics by Technology - Percentage Breakdown of Value Sales for Molecular Assays and Non-Molecular Assays for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Transplant Diagnostics by Product - Instruments, Reagent & Consumables and Software & Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Transplant Diagnostics by Product - Percentage Breakdown of Value Sales for Instruments, Reagent & Consumables and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제